AAAAAA

   
Results: 1-10 |
Results: 10
TRANS E1 COMPONENT REQUIREMENTS FOR MAXIMAL REPLICATION OF E1-DEFECTIVE RECOMBINANT ADENOVIRUS
Authors: GOLDSMITH KT DION LD CURIEL DT GARVER RI
Citation: Kt. Goldsmith et al., TRANS E1 COMPONENT REQUIREMENTS FOR MAXIMAL REPLICATION OF E1-DEFECTIVE RECOMBINANT ADENOVIRUS, Virology (New York, N.Y. Print), 248(2), 1998, pp. 406-419
RECOMBINANT ADENOVIRUS REPLICATION IN NONSMALL CELL LUNG-CANCER
Authors: GOLDSMITH KT DION LD GARVER RI
Citation: Kt. Goldsmith et al., RECOMBINANT ADENOVIRUS REPLICATION IN NONSMALL CELL LUNG-CANCER, Cancer gene therapy, 4(6), 1997, pp. 39-39
AMPLIFICATION OF RECOMBINANT ADENOVIRAL TRANSGENE PRODUCTS OCCURS BY INHIBITION OF HISTONE DEACETYLASE
Authors: DION LD GOLDSMITH KT TANG DC ENGLER JA YOSHIDA M GARVER RI
Citation: Ld. Dion et al., AMPLIFICATION OF RECOMBINANT ADENOVIRAL TRANSGENE PRODUCTS OCCURS BY INHIBITION OF HISTONE DEACETYLASE, Virology, 231(2), 1997, pp. 201-209
E1A RNA TRANSCRIPTS AMPLIFY ADENOVIRUS-MEDIATED TUMOR REDUCTION
Authors: DION LD GOLDSMITH KT STRONG TV BILBAO G CURIEL DT GARVER RI
Citation: Ld. Dion et al., E1A RNA TRANSCRIPTS AMPLIFY ADENOVIRUS-MEDIATED TUMOR REDUCTION, Gene therapy, 3(11), 1996, pp. 1021-1025
BUTYRATE-MEDIATED ADENOVIRAL TRANSGENE EXPRESSION AMPLIFICATION
Authors: DION LD GOLDSMITH KT TANG DC GARVER RI
Citation: Ld. Dion et al., BUTYRATE-MEDIATED ADENOVIRAL TRANSGENE EXPRESSION AMPLIFICATION, Cancer gene therapy, 3(6), 1996, pp. 50-50
NEW VECTORS MEDIATE CONTROLLED IN-SITU REPLICATION OF E1-DEFECTIVE ADENOVIRUS WITHOUT PRODUCTION REPLICATION-COMPETENT ADENOVIRUS
Authors: DION LD GOLDSMITH KT GARVER RI
Citation: Ld. Dion et al., NEW VECTORS MEDIATE CONTROLLED IN-SITU REPLICATION OF E1-DEFECTIVE ADENOVIRUS WITHOUT PRODUCTION REPLICATION-COMPETENT ADENOVIRUS, Cancer gene therapy, 3(6), 1996, pp. 51-51
E1A RNA TRANSCRIPTS AMPLIFY ADENOVIRAL-MEDIATED TUMOR REDUCTION
Authors: DION LD GOLDSMITH KT STRONG TV BILBAO G CURIEL DT GARVER RI
Citation: Ld. Dion et al., E1A RNA TRANSCRIPTS AMPLIFY ADENOVIRAL-MEDIATED TUMOR REDUCTION, Cancer gene therapy, 3(6), 1996, pp. 86-86
QUANTITATIVE AND IN-VIVO ACTIVITY OF ADENOVIRAL-PRODUCING CELLS MADE BY COTRANSDUCTION OF A REPLICATION-DEFECTIVE ADENOVIRUS AND A REPLICATION-ENABLING PLASMID
Authors: DION LD GOLDSMITH KT GARVER RI
Citation: Ld. Dion et al., QUANTITATIVE AND IN-VIVO ACTIVITY OF ADENOVIRAL-PRODUCING CELLS MADE BY COTRANSDUCTION OF A REPLICATION-DEFECTIVE ADENOVIRUS AND A REPLICATION-ENABLING PLASMID, Cancer gene therapy, 3(4), 1996, pp. 230-237
SUPERNATANT RESCUE ASSAY VS POLYMERASE CHAIN-REACTION FOR DETECTION OF WILD-TYPE ADENOVIRUS-CONTAMINATING RECOMBINANT ADENOVIRUS STOCKS
Authors: DION LD FANG J GARVER RI
Citation: Ld. Dion et al., SUPERNATANT RESCUE ASSAY VS POLYMERASE CHAIN-REACTION FOR DETECTION OF WILD-TYPE ADENOVIRUS-CONTAMINATING RECOMBINANT ADENOVIRUS STOCKS, Journal of virological methods, 56(1), 1996, pp. 99-107
EFFECTS OF TRANSFORMING GROWTH-FACTOR-BETA ON HUMAN FETAL ADRENAL-STEROID PRODUCTION
Authors: STANKOVIC AK DION LD PARKER CR
Citation: Ak. Stankovic et al., EFFECTS OF TRANSFORMING GROWTH-FACTOR-BETA ON HUMAN FETAL ADRENAL-STEROID PRODUCTION, Molecular and cellular endocrinology, 99(2), 1994, pp. 145-151
Risultati: 1-10 |